Mastering Your Injection: Where to Give Ozempic Shot in Stomach for Best Results

Last reviewed: July 7, 2026

Last updated: July 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections work by binding to GLP-1 receptors throughout your digestive system, but where you place the needle matters significantly for medication delivery. Choosing the correct abdominal injection site can enhance drug absorption, reduce injection discomfort, and minimize bruising. PlexusDx compounded semaglutide is administered subcutaneously—meaning just beneath the skin—and stomach placement offers several practical advantages for weekly dosing.

Understanding Subcutaneous Injection Anatomy for Semaglutide

Subcutaneous injections deposit medication into the fatty tissue layer between your skin and muscle, allowing steady absorption over time. The abdominal wall contains sufficient subcutaneous fat in most people, making it an ideal injection zone. This anatomical layer has fewer nerve endings than deeper tissues, which typically results in less injection pain compared to other body sites.

Semaglutide's mechanism depends on consistent, predictable absorption from the injection site. When you inject into areas with adequate subcutaneous tissue, the medication disperses evenly and reaches your bloodstream at a controlled rate. The stomach region provides this consistency week after week, supporting the steady GLP-1 receptor activation your body needs for appetite suppression and metabolic changes.

Best Stomach Injection Sites: The Lower Abdomen and Flanks

The lower abdomen, roughly two inches below your navel and extending to your sides, represents the preferred injection zone for semaglutide. This area has adequate fat padding, is easy to access with one hand, and allows you to visualize the injection site clearly. Many patients rotate between the lower abdomen's left and right sides to prevent repeated trauma to any single location.

Your flanks—the soft tissue along your sides just above the hip bone—offer an equally effective alternative. Flank injections provide good subcutaneous depth and excellent absorption characteristics. Rotating between lower abdominal and flank sites across your weekly injections distributes needle trauma and reduces the risk of lipohypertrophy, a thickening of fatty tissue that can occur with repeated injections in identical spots.

Injection Site Rotation: Preventing Complications and Maintaining Efficacy

Rotating your injection site is not optional—it's a critical safety practice that protects your skin and ensures consistent medication absorption. If you inject semaglutide into the same spot repeatedly, you risk developing lipohypertrophy or lipoatrophy, conditions that alter local fat tissue and can impair drug delivery. PlexusDx recommends establishing a simple rotation pattern: Week 1 lower left abdomen, Week 2 lower right abdomen, Week 3 left flank, Week 4 right flank, then repeat.

Each new injection should be at least one inch away from your previous site. Before injecting, visually inspect the planned area for redness, swelling, or bruising from prior doses. If you notice any inflammation or skin changes, move to a completely different zone on your abdomen or flank. Proper rotation maintains steady absorption rates and prevents the localized tissue damage that can reduce semaglutide effectiveness over months of treatment.

Preparing Your Stomach for Safe, Comfortable Semaglutide Injection

Clean the injection site thoroughly with an alcohol wipe and allow it to dry completely for at least 30 seconds before administering semaglutide. Injecting into wet skin introduces bacteria and can cause irritation or infection. Pinch the skin gently between your thumb and forefinger to create a fold, which increases subcutaneous tissue accessibility and reduces the chance of inadvertently reaching muscle tissue.

Insert the needle at a 45- to 90-degree angle, depending on your body composition and the needle length provided. Most semaglutide pens use short needles optimized for subcutaneous delivery into abdominal tissue. After injection, release the pinched skin and apply gentle pressure with a clean gauze pad if bleeding occurs. Never rub the injection site, as this can disperse the medication unevenly or increase bruising. If you experience persistent pain, severe swelling, or signs of infection within 24 hours, contact your healthcare provider immediately.

Personalized Injection Strategy: The Role of Genetic Factors in GLP-1 Response

Your genetic makeup influences how efficiently your body processes semaglutide and how well you tolerate the medication at various dose levels. Variants in the GLP1R gene (such as rs6923761) affect GLP-1 receptor density and sensitivity, potentially influencing both the drug's appetite-suppressing effect and your gastrointestinal side effect profile. PlexusDx Precision Peptide Genetic Test identifies these pathway differences and helps your provider optimize your semaglutide dosing and injection strategy.

The FTO gene variant (rs9939609) and MC4R gene variant (rs17782313) also shape your weight loss biology and may indicate whether you'll respond optimally to semaglutide alone or benefit from combination peptide therapy. Understanding your genetic predispositions allows PlexusDx providers to personalize not just your medication choice but also your dose progression timeline. Combined with proper injection technique and site rotation, genetic insights create a comprehensive, individualized approach to GLP-1 therapy success.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide into my thighs or upper arms instead of my stomach?

Yes—semaglutide can be injected into the thighs or upper arms as alternatives to the abdomen. However, the abdominal region offers superior consistency because subcutaneous fat depth is more uniform across that area. If you choose thighs or arms, maintain the same rigorous rotation schedule and site-spacing rules to prevent tissue complications.

How does injection site location affect semaglutide's absorption rate?

Subcutaneous injection sites with adequate fatty tissue—like the lower abdomen and flanks—provide predictable, steady absorption. Areas with thinner subcutaneous layers may show variable absorption rates. Research indicates that abdominal injections maintain stable GLP-1 blood levels week to week, supporting consistent appetite suppression and metabolic benefits throughout your treatment cycle.

What is PlexusDx compounded semaglutide, and how does it compare to brand-name Ozempic?

PlexusDx compounded semaglutide is prepared by licensed 503A compounding pharmacies using the same active ingredient as brand-name products, with flexible dosing options tailored to your needs. Compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with no insurance required, HSA/FSA eligible pricing, and availability across all 50 states. Your dose may need to go up. Your price won't.

What should I do if I develop bruising or swelling at my injection sites?

Minor bruising is normal and typically resolves within a few days. To minimize bruising, avoid injecting into bruised areas, apply ice before injection, and avoid blood-thinning medications if possible. Persistent swelling, redness lasting more than 48 hours, or signs of infection warrant immediate contact with your healthcare provider, as these may indicate lipohypertrophy or a localized reaction requiring site rest.

How can the PlexusDx Precision Peptide Genetic Test improve my semaglutide therapy?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (FTO) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Injection Ozempic
• Injection Sites For Ozempic
• Ozempic Injection Sites
• Ozempic Shot

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.